What Happened?
ADURO BIOTECH hired Tony Brew as Senior Director and Global Head of Information Technology and Information Technology Security
Date of management change: January 22, 2010
ADURO BIOTECH hired Tony Brew as Senior Director and Global Head of Information Technology and Information Technology Security
Aduro Biotech, Inc. is an immunotherapy company focused on the discovery, development and commercialization of therapies that transform the treatment of challenging diseases. Aduro`s technology platforms, which are designed to harness the body`s natural immune system, are being investigated in cancer indications and have the potential to expand into autoimmune and infectious diseases. Aduro`s LADD technology platform is based on proprietary attenuated strains of Listeria that have been engineered to express tumor-associated antigens to induce specific and targeted immune responses. Based on compelling clinical data in advanced cancers, this platform is being developed as a treatment for multiple indications, including pancreatic, ovarian, lung and prostate cancers, mesothelioma and glioblastoma. Aduro`s STING Pathway Activator platform is designed to activate the intracellular STING receptor, resulting in a potent tumor-specific immune response. Aduro`s B-select monoclonal antibody platform includes a number of immune modulating assets in research and preclinical development. Aduro is collaborating with leading global pharmaceutical companies to expand its products and technology platforms.
Tony Brew is Senior Director and Global Head of Information Technology and Information Technology Security at ADURO BIOTECH
News
Other IT executives who recently changed jobs as well: Kass Jonathan, Temitim Wen, Noto Dennis, Klump Thomas, Archuleta Michael, Reimer Dennis, Laporte Angel, Childs Melody, Mahes Ken, Grenga Anthony, Lawrence Andre
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.